EUVIMEDEUVIMED entdecken
Crossref

Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers

Julian F Guest iD

Journal of Wound Care · 2025

DOI: 10.12968/jowc.2025.0267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Wound Care, 2025. Verfasst von Julian F Guest. Beteiligte Einrichtung: Catalyst Consultants, Poole, UK. Hauptthemen laut MEDLINE: Varicose Ulcer, Wound Healing, Bandages, Silver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To estimate the cost-effectiveness of using a carboxymethylcellulose dressing containing ionic silver, ethylenediaminetetraacetic acid and benzethonium chloride (CISEB; Aquacel Ag+ Extra, Convatec Ltd., UK) compared with a dialkylcarbamoyl chloride-coated dressing (DACC; Cutimed Sorbact, Essity, Germany) in the treatment of hard-to-heal venous leg ulcers (VLUs), from the perspective of the UK's publicly-funded health services.

Method

Markov modelling simulated the management of hard-to-heal VLUs in the community and secondary care over 24 weeks. The modelling used data from a randomised controlled trial and estimated the relative cost-effectiveness of the two dressings, measured by the incremental cost per quality-adjusted life year (QALY) gained, based on 2022/23 prices.

Results

The findings of the modelling showed that starting treatment with CISEB instead of DACC resulted in a >25% increase in the probability of healing. However, the time to healing was similar in both groups, averaging at seven weeks per ulcer. The difference in the probability of healing between the two groups led to a cumulative gain in QALYs, resulting in a 5% improvement in health-related quality of life at 24 weeks. The higher healing rate in the CISEB group led to a ~14% reduction in the total cost of VLU management over 12 weeks and a 23% reduction over 24 weeks. Consequently, starting treatment with CISEB instead of DACC was identified as a potentially cost-effective intervention for treating hard-to-heal VLUs within the UK's health services, as it improved outcomes at a lower cost.

Conclusion

Considering the study's limitations, treating hard-to-heal VLUs with CISEB instead of DACC potentially offers a cost-effective strategy for the UK's health services, since it increases the likelihood of VLU healing for lower cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Varicose UlcerWound HealingBandagesSilverHumansCost-Benefit AnalysisQuality-Adjusted Life YearsCarboxymethylcellulose SodiumMarkov ChainsUnited KingdomMaleFemaleAged

Stichwörter der Autor:innen

Aquacel Ag+ ExtraCutimed SorbactDACCUKcost-effectivenessdialkylcarbamoyl chloride-coated dressingvenous leg ulcerwoundwound carewound dressingwound healing

Substanzen

Carboxymethylcellulose SodiumSilver

Autor:innen und Institutionen

  • Catalyst Consultants, Poole, UK.

ORCID-Profile: Julian F Guest

Zitieren

APA

Guest, J. F. (2025). Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers. Journal of Wound Care. https://doi.org/10.12968/jowc.2025.0267

Vancouver

Guest JF. Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers. Journal of Wound Care. 2025. doi:10.12968/jowc.2025.0267

BibTeX
@article{Guest2025,
  author = {Guest, Julian F},
  title = {Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers},
  journal = {Journal of Wound Care},
  year = {2025},
  doi = {10.12968/jowc.2025.0267}
}
Kostenlos starten →